Latest Prescription Drugs news
Biosimilars Could Cut Spending for Biologic Therapy in the U.S.
posted January 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Semaglutide Superior to Liraglutide for Weight Loss
posted January 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
U.S. Insurers Could Spend Millions for Ivermectin Rx for COVID-19
posted January 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Racial, Ethnic Disparities Seen in mAb Treatment for COVID-19
posted January 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy Related Articles
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
